CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 293 enrolled
Drug / intervention
As per routinary clinical careother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00793403
NCT00793403N/ACompleted
CompareCT.gov

Current Adoption Of Composite Indices In Evaluating Rheumatoid Arthritis Patients: An Observational Study ("NEW INDICES Study")

Pfizer·observational·Posted Nov 19, 2008·Updated Feb 4, 2013

In Brief

An observational study evaluating As per routinary clinical care for Rheumatoid Arthritis. Completed, enrolled 293 participants across 1 site.

Detailed Summary

This is an observational study of composite indices, including the CLARA (CLinical ARthritis Activity) index, in rheumatoid arthritis (RA) patients in routine clinical practice in Italy in order to evaluate clinical remission and low disease activity. Data will be collected only from patients providing informed consent. In this study we aimed to assess the psychometric properties of a new composite instrument termed CLinical ARthritis Activity (PRO-CLARA) that uses only three PRO measures from among the 7 ACR Core Data Set. We hypothesized that this index would facilitate rapid and easy RA activity assessment in daily routine.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatoid Arthritis
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 19, 2008
Enrollment StartJan 1, 2008
Primary CompletionJun 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 17.6 years ago

Interventions

As per routinary clinical careother

As per routine clinical care